arrow
A

Andrea Fontana

Fondazione IRCCS Casa Sollievo della Sofferenza
H指数:45
被引数:7,527

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR+/HER2+ early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17)

帕博西利尼联合来曲唑与每周紫杉醇对比,两者均联合曲妥珠单抗联合帕妥珠单抗,作为人表皮生长因子受体2阳性激素受体阳性早期乳腺癌患者的术前辅助治疗:随机II期TOUCH试验(IBCSG 55-17)的主要结果

2025-10-160
PRE
Development of a microRNA-based prognostic model for accurate prediction of distant metastasis in breast cancer patients

基于microRNA的预后模型开发,用于准确预测乳腺癌患者的远处转移

2025-10-030
OAAI
Variant sub-tiering, disease-gene associations and strictness of clinical criteria improves the interpretation of variants of uncertain significance in hereditary cardiomyopathies and rhythm disorders

变异亚分级、疾病-基因关联以及临床标准的严格性,可提高对遗传性心肌病和心律失常中意义不明的变异的解释。

2025-04-300
PRE
Tumor Suppressor miR-27a-5p and Its Significance for Breast Cancer
2024-11-170
OAAI
Efficacy of a Multistrain Synbiotic Treatment in Acute and Post-Acute COVID-19 Patients: A Double-Blind, Placebo-Controlled Randomized Trial
2024-07-161
OAAI
A powerful machine learning approach to identify interactions of differentially abundant gut microbial subsets in patients with metastatic and non-metastatic pancreatic cancer
2024-07-073
OAAI
Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis
2023-12-017
OAAI